These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Criteria for the surgical treatment of hypothalamo-hypophyseal-dependent Cushing's syndrome]. Ozyol MB; Voigt KH; Fehm HL; Schmidt K; Herfarth C Langenbecks Arch Chir; 1976; Suppl():87-90. PubMed ID: 1031834 [TBL] [Abstract][Full Text] [Related]
3. Nelson's syndrome after Cushing's disease in childhood: a continuing problem. Thomas CG; Smith AT; Benson M; Griffith J Surgery; 1984 Dec; 96(6):1067-77. PubMed ID: 6505960 [TBL] [Abstract][Full Text] [Related]
4. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease. van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342 [TBL] [Abstract][Full Text] [Related]
5. [Is it possible to predict the development of Nelson's syndrome in Cushing's disease after bilateral adrenalectomy?]. Horký K; Kanka J; Gregorová I; Tomsová Z; Dvoráková J Cas Lek Cesk; 1990 May; 129(21):645-9. PubMed ID: 2164450 [TBL] [Abstract][Full Text] [Related]
6. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A; Murray RD; Teasdale GM; Shalet SM Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963 [TBL] [Abstract][Full Text] [Related]
7. Malignant evolution of an ACTH-producing pituitary tumor treated with intrasellar implantation of 90Y. Case report and review of the literature. Papotti M; Limone P; Riva C; Gatti G; Bussolati G Appl Pathol; 1984; 2(1):10-21. PubMed ID: 6098287 [TBL] [Abstract][Full Text] [Related]
8. Incidence of Nelson's syndrome and residual adrenocortical function in patients of Cushing's disease after bilateral adrenalectomy. Misra D; Kapur MM; Gupta DK J Assoc Physicians India; 1994 Apr; 42(4):304-5. PubMed ID: 7860549 [TBL] [Abstract][Full Text] [Related]
9. ACTH secretory responsiveness of pituitary adrenotroph cell tumor to adrenocorticotropin-releasing factor in Cushing's disease and Nelson's syndrome. Takeda R; Ito T; Kawato M; Nakabayashi H; Miyamori I; Morise T; Koshida H; Ikeda M Exp Clin Endocrinol; 1986 Jun; 87(1):31-7. PubMed ID: 3017732 [TBL] [Abstract][Full Text] [Related]
11. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease. Flitsch J; Knappe UJ; Lüdecke DK Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940 [TBL] [Abstract][Full Text] [Related]
12. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)]. Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921 [TBL] [Abstract][Full Text] [Related]
13. CRH in Cushing's syndrome. Müller OA; Stalla GK; von Werder K Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289 [TBL] [Abstract][Full Text] [Related]